89bio, Inc.

NASDAQ:ETNB

8.47 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -367.079-142.189-102.026-90.122-49.499-57.42-16.176
Depreciation & Amortization -9.1410.050.0650.0790.060.0170.006
Deferred Income Tax 00.1270-0.15-0.0690.02-0.02
Stock Based Compensation 20.63416.10610.3568.6783.8070.3890.108
Change In Working Capital -14.5280.65710.5563.252-1.0410.9372.634
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 7.058-3.9175.6594.7781.131-0.521.509
Other Working Capital -21.5864.5744.897-1.526-2.1721.4571.125
Other Non Cash Items 2.291-3.937-0.0411.4820.49830.5970.979
Operating Cash Flow -367.823-129.186-81.09-76.781-46.244-25.46-12.469
Investing Activities:
Investments In Property Plant And Equipment -0.015-0.004-0.007-0.063-0.126-0.139-0.039
Acquisitions Net 000.034-0.0070.10700
Purchases Of Investments -376.074-341.148-152.696-141.2-118.89500
Sales Maturities Of Investments 335.225218.133118.76148.42212.18900
Other Investing Activites 00-0.0340.007-0.10700
Investing Cash Flow -40.864-123.019-33.9437.159-106.832-0.139-0.039
Financing Activities:
Debt Repayment 9.3492.963019.951000.1
Common Stock Issued 157.574496.565116.9973.776157.6887.70223.665
Common Stock Repurchased 0.3560.26800000
Dividends Paid 0000000
Other Financing Activities 51.66313.5830.8340.1440.2442023.665
Financing Cash Flow 218.586513.111117.83123.871157.924107.70223.765
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -190.101260.9062.798-45.7514.84882.10311.257
Cash At End Of Period 126.06316.16155.25552.45798.20893.3611.257